Development of Blood Stage Malaria Vaccines.

作者: Aneesh Vijayan , Chetan E. Chitnis

DOI: 10.1007/978-1-4939-9550-9_15

关键词: Immune mechanismsImmune systemImmunologyPlasmodiumVaccine efficacyBlood stageMalariaBlood stage malariaMedicine

摘要: The blood stage of the malaria parasite life cycle is responsible for all clinical symptoms malaria. During stage, Plasmodium merozoites invade and multiply within host red cells (RBCs). Here, we review progress made, challenges faced, new strategies available development vaccines. We discuss our current understanding immune responses against stages status various vaccine candidates. then possible paths forward to develop effective This includes a discussion protective mechanisms that can be elicited target parasites, novel delivery systems, immunoassays animal models optimize candidates in preclinical studies, use challenge get an early readout efficacy.

参考文章(114)
T. Alderson, A. W. Thomas, S. Cohen, G. H. Mitchell, Judith A. Deans, E. S. Lennox, Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clinical and Experimental Immunology. ,vol. 49, pp. 297- 309 ,(1982)
C Oeuvray, H Bouharoun-Tayoun, H Gras-Masse, E Bottius, T Kaidoh, M Aikawa, MC Filgueira, A Tartar, P Druilhe, Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes Blood. ,vol. 84, pp. 1594- 1602 ,(1994) , 10.1182/BLOOD.V84.5.1594.1594
Simone C. de Cassan, A. Rushdi Shakri, David Llewellyn, Sean C. Elias, Jee Sun Cho, Anna L. Goodman, Jing Jin, Alexander D. Douglas, Rossarin Suwanarusk, François H. Nosten, Laurent Rénia, Bruce Russell, Chetan E. Chitnis, Simon J. Draper, Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax Frontiers in Immunology. ,vol. 6, pp. 348- 348 ,(2015) , 10.3389/FIMMU.2015.00348
Jingling Zhou, Gaoqian Feng, James Beeson, P. Mark Hogarth, Stephen J. Rogerson, Yan Yan, Anthony Jaworowski, CD14 hi CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so BMC Medicine. ,vol. 13, pp. 290- 290 ,(2015) , 10.1186/S12916-015-0530-1
Ali Jafarshad, Morten H. Dziegiel, Rasmus Lundquist, Leif K. Nielsen, Subhash Singh, Pierre L. Druilhe, A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes FcγRII and FcγRIII Journal of Immunology. ,vol. 178, pp. 3099- 3106 ,(2007) , 10.4049/JIMMUNOL.178.5.3099
Michal Fried, Patrick E. Duffy, Designing a VAR2CSA-based vaccine to prevent placental malaria Vaccine. ,vol. 33, pp. 7483- 7488 ,(2015) , 10.1016/J.VACCINE.2015.10.011
S. COHEN, I. A. McGREGOR, S. CARRINGTON, Gamma-Globulin and Acquired Immunity to Human Malaria Nature. ,vol. 192, pp. 733- 737 ,(1961) , 10.1038/192733A0
Wandy L. Beatty, Ababacar Diouf, Raul Herrera, Xavier Ambroggio, J. Kathleen Moch, Jessica S. Tyler, David L. Narum, Susan K. Pierce, John C. Boothroyd, J. David Haynes, Louis H. Miller, Prakash Srinivasan, Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 13275- 13280 ,(2011) , 10.1073/PNAS.1110303108
Susanne H Sheehy, Christopher JA Duncan, Sean C Elias, Prateek Choudhary, Sumi Biswas, Fenella D Halstead, Katharine A Collins, Nick J Edwards, Alexander D Douglas, Nicholas A Anagnostou, Katie J Ewer, Tom Havelock, Tabitha Mahungu, Carly M Bliss, Kazutoyo Miura, Ian D Poulton, Patrick J Lillie, Richard D Antrobus, Eleanor Berrie, Sarah Moyle, Katherine Gantlett, Stefano Colloca, Riccardo Cortese, Carole A Long, Robert E Sinden, Sarah C Gilbert, Alison M Lawrie, Tom Doherty, Saul N Faust, Alfredo Nicosia, Adrian VS Hill, Simon J Draper, ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans Molecular Therapy. ,vol. 20, pp. 2355- 2368 ,(2012) , 10.1038/MT.2012.223